Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence

Vaccine

Volumn 23, Issue 21, 2005, Pages 2711-2716

  Janaszek Seydlitz, Wieslawa ^a   Bucholc, Bozena ^a   Gorska, Paulina ^a   Slusarczyk, Janusz ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Epidemiology; Mumps; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNIZATION; MALE; MUMPS; MUMPS VIRUS; POLAND; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; TIME SERIES ANALYSIS; VACCINATION;

EID: 15044354725     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.050     Document Type: Article

References (19)

1. A.M. Galazka, S.E. Robertson, and A. Krajgher Mumps and mumps vaccine: a global review Bull WHO 77 1999 3 14
2. W.A. Falk, K. Buchan, and M. Dow The epidemiology of mumps in Southern Alberta Am J Epidemiol 130 1989 736 749
3. B.M. Minja Aetiology of deafness among children at the Buguruni School for the Deaf in Dar es Salaam Tanzania Int J Pediatr Otorhinol 42 1998 225 231
4. C.Y. Lin, W.P. Chen, and H. Chiang Mumps associated with nephritis Child Nephrol Urol 10 1990 68 71
5. Mumps virus vaccines. Wkly Epidemiol Rec 2001; 76: 346-55.
6. W. Janaszek, and W. Gut Prevalence of measles virus antibodies in the populations of chosen voivodeships in Poland Przegl Epidemiol 53 1999 291 298
7. W. Janaszek, W. Gut, and N.J. Gay The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population Epidemiol Infect 125 2000 385 392
8. W. Janaszek, N.J. Gay, and W. Gut Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland Vaccine 21 2003 473 478
9. P.E. Slater, M. Roitman, and C. Costin Mumps incidence in Israel - impact of MMR vaccine Public Health Rev 18 1991 88 93
10. V. Bakasun Mumps in the region of Rijeka, Croatia Eur J Epidemiol 13 1997 117 119
11. N.J. Gay, E. Miller, and L. Hesketh Mumps surveillance in England and Wales supports introduction of a two dose vaccination schedule Commun Dis Rep 7 1997 R21 R26
12. H. Peltola, O.P. Heinonen, and M. Valle The elimination of indigenous measles, mumps and rubella from Finland by a 12-years, two doses vaccination program N Engl J Med 331 1994 1397 1402
13. M. Koskiniemi, and A. Vaheri Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children Lancet 1 1989 31 34
14. N. Darin, P. Hanner, and K. Thiringer Changes in prevalence, aetiology, age at detection, and associated disabilities in preschool children with hearing impairment born in Göteborg Dev Med Child Neurol 39 1997 797 802
15. WHO Regional Office for Europe. Operational targets for EPI disease. Unpublished document EUR/ICP/CMDS 010114 Rev. 1. Copenhagen, World Health Organization, 1996.
16. N.O. Kanbur, O. Derman, and T. Kutluk Age-specific mumps seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey Jpn J Infect Dis 56 2003 213 215
17. P. Morgan-Capner, J. Wright, C.L. Miller, and E. Miller Surveillance of antibody to measles, mumps, and rubella by age Br Med J 297 1988 770 772
18. J.H. Wagenvoort, B. Harmsen, B.J. Boutahar-Trouw, C.A. Kraaijeveld, and K.C. Winkler Epidemiology of mumps in the Netherlands J Hyg 85 1980 313 326
19. D. Imbs, M. Loza-Tulimowska, and H. Rudnicka Occurrence of antibodies against mumps virus in the population of Poland Przegl Epidemiol 38 1984 361 368